164 related articles for article (PubMed ID: 20136830)
1. Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti-allodynic effects.
Ueda M; Iida Y; Tominaga A; Yoneyama T; Ogawa M; Magata Y; Nishimura H; Kuge Y; Saji H
Br J Pharmacol; 2010 Mar; 159(6):1201-10. PubMed ID: 20136830
[TBL] [Abstract][Full Text] [Related]
2. In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects.
Ueda M; Iida Y; Yoneyama T; Kawai T; Ogawa M; Magata Y; Saji H
Synapse; 2011 Jan; 65(1):77-83. PubMed ID: 20506320
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
[TBL] [Abstract][Full Text] [Related]
5. ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model.
Lynch JJ; Wade CL; Mikusa JP; Decker MW; Honore P
Eur J Pharmacol; 2005 Feb; 509(1):43-8. PubMed ID: 15713428
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
7. Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain.
Dubé GR; Kohlhaas KL; Rueter LE; Surowy CS; Meyer MD; Briggs CA
Neurosci Lett; 2005 Mar; 376(1):29-34. PubMed ID: 15694269
[TBL] [Abstract][Full Text] [Related]
8. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
[TBL] [Abstract][Full Text] [Related]
9. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
[TBL] [Abstract][Full Text] [Related]
10. Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594.
Munro G; Dyhr H; Grunnet M
Neuropharmacology; 2010 Sep; 59(3):208-17. PubMed ID: 20562022
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury.
Kiguchi N; Kobayashi D; Saika F; Matsuzaki S; Kishioka S
J Neuroinflammation; 2018 Mar; 15(1):96. PubMed ID: 29587798
[TBL] [Abstract][Full Text] [Related]
13. 5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons.
Ueda M; Iida Y; Kitamura Y; Kawashima H; Ogawa M; Magata Y; Saji H
Brain Res; 2008 Mar; 1199():46-52. PubMed ID: 18269932
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.
Freitas KC; Carroll FI; Negus SS
J Pharmacol Exp Ther; 2015 Nov; 355(2):341-50. PubMed ID: 26359313
[TBL] [Abstract][Full Text] [Related]
16. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
[TBL] [Abstract][Full Text] [Related]
17. The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.
Decker MW; Curzon P; Holladay MW; Nikkel AL; Bitner RS; Bannon AW; Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Williams M; Arneric SP
J Physiol Paris; 1998; 92(3-4):221-4. PubMed ID: 9789812
[TBL] [Abstract][Full Text] [Related]
18. Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain.
Bertorelli R; Fredduzzi S; Tarozzo G; Campanella M; Grundy R; Beltramo M; Reggiani A
Behav Brain Res; 2005 Feb; 157(1):55-62. PubMed ID: 15617771
[TBL] [Abstract][Full Text] [Related]
19. Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study.
Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Kawashima H; Fukuyama H; Togashi K; Saji H
J Nucl Med; 2007 Nov; 48(11):1829-35. PubMed ID: 17942810
[TBL] [Abstract][Full Text] [Related]
20. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
Meyer MD; Decker MW; Rueter LE; Anderson DJ; Dart MJ; Kim KH; Sullivan JP; Williams M
Eur J Pharmacol; 2000 Mar; 393(1-3):171-7. PubMed ID: 10771011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
